ArticleCancer medicine2023

Immunotherapy or antiangiogenic therapy plus chemotherapy as first-line treatment of patients with PD-L1(-) advanced non-squamous non-small cell lung cancer in a Chinese cohort.

Ruolan Xia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.